Clinical Trial Update: Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease [Phase 2]

View source ↗

Summary

This report covers an ongoing Phase 2 clinical trial of Afimkibart (RO7790121) for moderate to severe active Crohn's disease and notes the study status as activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Afimkibart (RO7790121)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Crohns Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING